Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: Digital Measures for Clinical Trial Endpoints in Huntington's Disease

View source ↗

Summary

A University of Rochester–led clinical trial is evaluating digital measures as endpoints in Huntington's disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Rochester | Conditions: Huntington Disease, Healthy | Status: RECRUITING